NCT05341739
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must agree to undergo surgical resection to manage at least 1 brain metastasis
Exclusions: Patients with prior whole brain radiotherapy (WBRT) or radiation therapy directed to index brain metastases; Patients with brain metastasis greater than or equal to 5 cm in maximum diameter
https://ClinicalTrials.gov/show/NCT05341739